Life Tech Eyes Long-Term Opportunities in Synthetic Bio Space

With two recent deals, Life Tech hopes to capitalize on the synthetic biology market, which is projected to grow to $2.4 billion by 2013.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.